Report Highlights
The global market for digital polymerase chain reaction (dPCR) technology is expected to grow from $752.1 million in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023-2028.
Report Includes
- 26 data tables and 37 additional tables
- An overview and analysis of the global market for digital polymerase chain reaction (dPCR) technology
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
- Estimates of the market size and revenue forecast for global dPCR market, and corresponding analysis of market shares by product type, technology, end-use and region
- In-depth information (facts and figures) pertaining to the major factors influencing the market, including drivers, restraints, opportunities and challenges
- A value chain analysis providing a systematic study of the key intermediaries, with emphasis on manufacturers, suppliers and major end users
- Discussion of the importance of ESG in the dPCR technology market, including consumer attitudes, an assessment of risks and opportunities, and the ESG practices followed by manufacturers and service providers
- Analysis of the U.S. patents on digital PCR, and emerging trends and technologies in the industry
- A look at the major vendors in the global market for dPCR, and an analysis of the industry structure, including market shares and recent M&A activity
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, key financials and revenues by segment
- Company profiles of the leading market players
Report Scope
This research study analyzes the dPCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, technology, end-use and region from 2023 through 2028.
The report also analyzes leading and emerging competitors in the current worldwide dPCR market.
Report Synopsis
Report Metrics | Details | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2022 | ||||||||||||
Forecast period considered | 2023-2028 | ||||||||||||
Base year market size | $677.6 million | ||||||||||||
Market size forecast | $1.3 billion | ||||||||||||
Growth rate | CAGR of 11.0% from 2023 to 2028 | ||||||||||||
Units considered | $ Millions | ||||||||||||
Segments covered | By Product Type, Technology, End Use, and Region | ||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||
Key Market Drivers |
|
||||||||||||
Companies studied |
|
Frequently Asked Questions (FAQs)
- Technological advancements.
- Growing demand in clinical diagnostics.
- Burgeoning biopharmaceutical market.
- Growth in genomic and biomarker research.
- Trends towards personalized medicine.
- Robust funding environment for biomedical research.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Digital Pathology: Technologies and Global Markets
The global digital pathology market is expected to grow from $7.8 billion in 2024 and is projected to reach $13.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.9% during the forecast period of 2024 to 2029.
2024 Diagnostics Research Review
The Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Rare Disease Diagnostics: Technologies and Global Markets
The global market for rare disease diagnostics is estimated to increase from $21.6 billion in 2024 to reach $34.7 billion by 2029, at a compound annual growth rate (CAGR) of 9.9% from 2024 through 2029.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Global Irritable Bowel Syndrome and Inflammatory Bowel Disease Therapeutics Market
The global market for irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) therapeutics is expected to grow from $33.3 billion in 2025 and is projected to reach $52.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 9.6% during the forecast period of 2025 to 2030.
Global DNA Forensics Market
The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.
Global Blood Platelet Market
The global market for blood platelets is expected to grow from $3.2 billion in 2025 and is projected to reach $4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 4.6% during the forecast period of 2025 to 2030.
Digital Biomarkers: Global Markets
The global market for digital biomarkers is estimated to grow from $5 billion in 2025 to $18.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 30.4% from 2025 through 2030.
Whole Genome Sequencing: Global Markets
The global market for whole genome sequencing is expected to grow from $3 billion in 2025 and forecast to reach $6.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 15.1% from 2025 to 2030.
Top Trending Reports
Sensors: Technologies and Global Markets
The global market for sensors was valued at $195.1 billion in 2024 and is estimated to increase from $212.5 billion in 2025 to reach $323.3 billion by 2030, at a compound annual growth rate (CAGR) of 8.7% from 2025 through 2030.
Global Cell Line and Membrane Market
The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.
Water and Wastewater Treatment Technologies: Global Markets
The global market for water and wastewater treatment technologies is expected to grow from $350.7 billion in 2025 and is projected to reach $591.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2025 to 2030.
Global Edge AI Market
The global market for edge AI was valued at $8.7 billion in 2024 and is estimated to increase from $11.8 billion in 2025 to reach $56.8 billion by 2030, at a compound annual growth rate (CAGR) of 36.9% from 2025 through 2030.
Global Biochip Markets: Microarrays and Lab-on-a-Chip
The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.
Report Highlights
The global digital polymerase chain reaction (PCR) technology market totaled $425.0 million in 2017 and is estimated to reach $746.0 million by 2022, growing at a compound annual growth rate (CAGR) of 11.9% for the period of 2017-2022.
Report Includes
- 14 data tables and 7 additional tables
- An overview of the global market for digital polymerase chain reaction (PCR) technology
- Analyses of global market trends, with data from 2016, and estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Discussion of key manufacturers, suppliers, users, and a variety of factors influencing demand
- Relevant Patent analyses
- Comprehensive company profiles of major players in the market, including Abbott Laboratories, Celula Inc., Fluidigm Corp., IntegenX Inc. and Stilla Technologies
Report Highlights
The global market for digital polymerase chain reaction (PCR) technology reached $81.8 million in 2012 and $139.3 million in 2013. The market is expected to grow to $489.8 million in 2018, a compound annual growth rate (CAGR) of 28.6% for the five-year period, 2013 to 2018.
Report Includes
- An overview of the global market for digital polymerase chain reaction (PCR) technology
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Discussion on key manufacturers, suppliers, users and a variety of factors influencing demand
- Relevant patent analysis
- Comprehensive profiles of major players in the industry.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More